Multi-cohort transcriptomic subtyping of B-cell acute lymphoblastic leukemia

VP Mäkinen, J Rehn, J Breen, D Yeung… - International Journal of …, 2022 - mdpi.com
RNA sequencing provides a snapshot of the functional consequences of genomic lesions
that drive acute lymphoblastic leukemia (ALL). The aims of this study were to elucidate …

Predicting the influence of Circ_0059706 expression on prognosis in patients with acute myeloid leukemia using classical statistics and machine learning

J Ma, X Wen, Z Xu, P Xia, Y Jin, J Lin, J Qian - Frontiers in genetics, 2022 - frontiersin.org
Background: Various circular RNA (circRNA) molecules are abnormally expressed in acute
myeloid leukemia (AML), and associated with disease occurrence and development, as well …

Spectrum of genetic mutations in Korean pediatric acute lymphoblastic leukemia

JW Yoo, A Ahn, JM Lee, S Jo, S Kim, JW Lee… - Journal of Clinical …, 2022 - mdpi.com
The wide application of next-generation sequencing (NGS) technologies has led to the
discovery of multiple genetic alterations in pediatric acute lymphoblastic leukemia (ALL). In …

APAview: A web-based platform for alternative polyadenylation analyses in hematological cancers

X Hu, J Song, J Chyr, J Wan, X Wang, J Du… - Frontiers in …, 2022 - frontiersin.org
Background: Hematologic malignancies, such as acute promyelocytic leukemia (APL) and
acute myeloid leukemia (AML), are cancers that start in blood-forming tissues and can affect …

Detection of novel PPP1R1B::STARD3 fusion transcript in acute myeloid leukemia: a case report

ED Firouzabadi, M Allami, EJ Mohammed… - Journal of Medical Case …, 2024 - Springer
Background Acute myeloid leukemia (AML) is the second most common type of leukemia in
children. Although prognostic and diagnostic tests of AML patients have improved, there is …

Genetic characteristics according to subgroup of acute myeloid leukemia with myelodysplasia-related changes

D Kang, J Jung, S Park, BS Cho, HJ Kim, Y Kim… - Journal of Clinical …, 2022 - mdpi.com
Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) includes
heterogeneous conditions such as previous history and specific cytogenetic and …